
|Articles|November 15, 2002
Separate and combined drug therapy both work to lower IOP
Los Angeles-A randomized, controlled trial comparing the combination therapy dorzolamide-timolol (Cosopt, Merck) with concomitant administration of 2% dorzolamide (Trusopt, Merck) and 0.5% timolol showed that the IOP lowering is equally effective if the drugs are given either in combination or individually.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA accepts resubmitted ONS-5010 BLA from Outlook Therapeutics
2
Five-year GALE study data announced
3
Post-hoc AREDS2 analysis highlights distinct mechanisms driving GA progression
4
AAO 2025: Effect of cryopreserved amniotic membrane after corneal cross-linking in patients with keratoconus
5



















































.png)


